Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase I : Cediranib in Combination With Lomustine Chemotherapy in Recurrent Malignant Brain Tumour
This study is ongoing, but not recruiting participants.
Study NCT00503204 Information provided by AstraZeneca
First Received: July 16, 2007 Last Updated: September 3, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Recurrent Glioblastoma
Brain Tumor
Additional conditions recognized in this trial
Brain Neoplasms
Glioblastoma
Recurrence
More general conditions related to this trial
Astrocytoma
Brain Diseases
Central Nervous System Diseases
Central Nervous System Neoplasms
Disease Attributes
Glioma
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Germ Cell and Embryonal
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue
Neoplasms, Neuroepithelial
Nervous System Diseases
Nervous System Neoplasms
Neuroectodermal Tumors
Pathologic Processes
Interventions listed in this trial
Cediranib
Lomustine
More general drug interventions related to this trial
Alkylating Agents
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
AstraZeneca
Back to top of Main Content
